PPT-Changing Pathways: Improving outcomes and saving lives of individuals with Opioid Use

J Craig Allen MD FASAM Carrie Bourdon LCSW Sandrine Pirard MD PhD MPH Nothing to Disclose Agenda 1 Scope of Opioid Overdose Crisis 2 Medications for Opioid Use Disorder MOUD 3. John e lopes . j. r. .. , . dhs. c. , pa-c. A. ssociate Professor, . Physician Assistant Program. Central Michigan University. and . Project Director. Medication-assisted Treatment Waiver Training Initiative. Analgesics and Opioids. Analgesics are drugs that relieve pain without causing loss of consciousness.. Opioids are the . most effective pain relievers available.. Terminology. Opioid. . A general term defined as any drug, natural or synthetic, that . Dr. Gretchen Schmidt. Executive Director, Pathways Project. October . 27, 2016. How did we get here?. Achieving the Dream. Over a . decade of institutional reform. Developmental Education Initiative. Angeline Stanislaus, MD. Chief Medical director- adult services. Missouri . Dept. of Mental Health. How many people are dying each day?. 115. Overdoses. Missouri- Total number of opioid related death 2017. Ernest J Dole, PharmD, . PhC. , FASHP, BCPS. Clinical Pharmacist & . Asso. . Clinical Prof.. University of New Mexico Hospitals & College of Pharmacy. Albuquerque, NM. Learning Objectives. At the end of this presentation, utilizing a case of an older patient on chronic opioid therapy (COT) with the comorbidity of geriatric opioid abuse (GOA) the participant will be able to. Get Started with Using Pathways A Beginner’s Guide on using Pathways and where to get help! Ray Rivero DTM 30 March 2019 2 Workshop Objectives Introduction to Pathways How to Access Pathways Joshua Blum MD. April 7, 2018. No relevant financial disclosures. Learning objectives. Utilize the latest evidence around opioid-induced hyperalgesia to mitigate negative consequences . Implement best practices around opioid rotation to manage OIH. : . Addressing Fear and Discrimination (Part I). Sharon Morello RN, BSN . Opioid Epidemic and Substance Use Disorders. . Heroin use climbed then stabilized . See table 7.2 in the 2017 NSDUH detailed tables for additional information and the 2017 CDC Mortality Data.. William J. Lorman, JD, PhD, MSN, PMHNP-BC, CARN-AP. V. P. & Chief Clinical Officer, Livengrin Foundation, Inc.. Ass’t. Clinical Professor, Doctoral Nursing Dept., . Drexel University. wlorman@livengrin.org. Peggy Compton, PhD, RN, FAAN. Associate Professor. van . Ameringen. Endowed Chair. Department of Family and Community Health. University of Pennsylvania School of Nursing. Betty Ford Award Plenary. or both?. Joshua Blum MD. February 17, 2021. Objectives. Understand the overlapping prevalence and features of chronic pain and addiction. Describe the continuum from chronic pain to opioid use disorder and recognize where individual patients are positioned on this continuum. This . project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under contract number HHSH250201600015C. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.. Farinaz . Khan, . Paul . Romo, MD. Disclosure. None. Outline. Opioids and the Neuroendocrine system. Misuse and Addiction. Treatment . Special Populations- forensics. Objective. By the end of this didactic, you will be able to:. TOGETHER, WE ARE UNITING TO HELP.. togetherarkansas.com. +. ARKANSAS HAS THE . 2ND HIGHEST. . OPIOID USE RATE IN THE NATION. . O. pioid use. disorder is affecting businesses . of every kind — . from small operations to large .